Efficacy of Acupuncture and Moxibustion as a Subsequent Treatment after Second-Line Chemotherapy in Advanced Gastric Cancer
- PMID: 33144870
- PMCID: PMC7599393
- DOI: 10.1155/2020/8274021
Efficacy of Acupuncture and Moxibustion as a Subsequent Treatment after Second-Line Chemotherapy in Advanced Gastric Cancer
Abstract
Objective: To explore whether acupuncture and moxibustion can prevent disease progression of advanced gastric cancer patients completing second-line chemotherapy and, if so, the related mechanism.
Method: Progression-free survival (PFS) and overall survival (OS) were main outcome measures. The real-time quantitative PCR was used to detect the expression of genes including T-bet, IFN-γ, GATA3, and IL-4 in peripheral blood mononuclear cells (PBMCs). IL-4, IL-6, Ca199, CRP, and IFN-γ in plasma levels were checked.
Results: 170 patients were randomly assigned in a 3 : 2 ratio to receive either acupuncture and moxibustion or sham acupuncture until progression. 135 patients were included in the primary analysis. Both PFS and OS in treatment group were proven to be better than control group. Acupuncture and moxibustion promoted typical Th1 cells drifting, as confirmed by increased T-bet/IFN-γ and decreased GATA3/IL-4 in mRNA levels from PBMCs, as well as upregulating IFN-γ and downregulating IL-4 in plasma levels. IL-6, Ca199, and CRP in plasma levels were also reduced by acupuncture and moxibustion.
Conclusions: Acupuncture and moxibustion can prolong PFS and OS of advanced gastric cancer patients completing second-line chemotherapy by reversing Th1/Th2 shift and attenuating inflammatory responses.
Copyright © 2020 Yong-jie Zhang et al.
Conflict of interest statement
All authors have no conflicts of interest with respect to the manuscript.
Figures



Similar articles
-
Electro-acupuncture at Acupoint ST36 Ameliorates Inflammation and Regulates Th1/Th2 Balance in Delayed-Type Hypersensitivity.Inflammation. 2017 Apr;40(2):422-434. doi: 10.1007/s10753-016-0487-z. Inflammation. 2017. PMID: 27966183
-
Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.J Rheumatol. 2007 Jan;34(1):89-96. Epub 2006 Nov 15. J Rheumatol. 2007. PMID: 17117487
-
[Impact of cyclosporine A on the expression of T-bet, GATA-3, relevant signal transduction molecules, cytokine and Th1/Th2 balance in patients with chronic aplastic anemia].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Oct;18(5):1211-9. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010. PMID: 21129263 Chinese.
-
Expression of Th1 and Th2 cytokine-associated transcription factors, T-bet and GATA-3, in peripheral blood mononuclear cells and skin lesions of patients with psoriasis vulgaris.Arch Dermatol Res. 2010 Sep;302(7):517-23. doi: 10.1007/s00403-010-1048-1. Epub 2010 Mar 24. Arch Dermatol Res. 2010. PMID: 20333526
-
[A literature review on acupuncture and moxibustion for prevention and treatment of lung cancer in SCI iournals (2003-2013)].Zhongguo Zhen Jiu. 2015 Jun;35(6):638-40. Zhongguo Zhen Jiu. 2015. PMID: 26480578 Review. Chinese.
Cited by
-
Mechanistic insights into the role of traditional Chinese medicine in treating gastric cancer.Front Oncol. 2025 Jan 21;14:1443686. doi: 10.3389/fonc.2024.1443686. eCollection 2024. Front Oncol. 2025. PMID: 39906672 Free PMC article. Review.
-
Acupuncture for Quality of Life in Gastric Cancer Patients Undergoing Adjuvant Chemotherapy.J Pain Symptom Manage. 2022 Feb;63(2):210-220. doi: 10.1016/j.jpainsymman.2021.09.009. Epub 2021 Sep 23. J Pain Symptom Manage. 2022. PMID: 34563627 Free PMC article. Clinical Trial.
-
Treatment Alternative and High Safety Profile of Acupuncture Plus Chemotherapy for Advanced Gastric Cancer.Evid Based Complement Alternat Med. 2022 Jul 30;2022:8701779. doi: 10.1155/2022/8701779. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35942375 Free PMC article.
-
Clinical Efficacy of Acupuncture on Neoadjuvant Chemotherapy with Capecitabine plus Paclitaxel and Radiotherapy in Progressive Gastric Cancer.J Oncol. 2022 Jul 12;2022:6156585. doi: 10.1155/2022/6156585. eCollection 2022. J Oncol. 2022. PMID: 35865087 Free PMC article.
References
-
- Nishikawa H., Sakaguchi S. Regulatory T cells in tumor immunity. International Journal of Cancer. 2011;127(4):759–767. - PubMed
-
- Xu Y., Gao J. J., Su Z. L., et al. Downregulation of Hlx closely related to the decreased expressions of T-bet and Runx3 in Patients with gastric cancer may be associated with a pathological event leading to the imbalance of Th1/Th2. Clinical and Developmental Immunology. 2012;2012:8. doi: 10.1155/2012/949821.949821 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous